Evidence map›Paper›PMID 31356587›Full record

ArticlePLoS neglected tropical diseases2019

CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge.

Camila Pontes Ferreira, Leonardo Moro Cariste, Barbara Ferri Moraschi, Bianca Ferrarini Zanetti, Sang Won Han, Daniel Araki Ribeiro, Alexandre Vieira Machado, Joseli Lannes-Vieira, Ricardo Tostes Gazzinelli, José Ronnie Carvalho Vasconcelos

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Camila Pontes FerreiraDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil.
Leonardo Moro CaristeDepartment of Biosciences, Federal University of São Paulo, Santos, Brazil.
Barbara Ferri MoraschiDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil.
Bianca Ferrarini ZanettiDepartment of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Sang Won HanDepartment of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Daniel Araki RibeiroDepartment of Biosciences, Federal University of São Paulo, Santos, Brazil.
Alexandre Vieira MachadoRené Rachou Research Center, Fiocruz, Minas Gerais, Brazil.
Joseli Lannes-VieiraLaboratory of Biology of the Interactions, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil.
Ricardo Tostes GazzinelliRené Rachou Research Center, Fiocruz, Minas Gerais, Brazil.
José Ronnie Carvalho VasconcelosDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-1126-7563
Universidade Federal de São Paulo · BRFundação Oswaldo Cruz · BRUniversity of Massachusetts Chan Medical School · US

Funding

Granzyme and Granulysin Mediated Death of Trypanosoma cruziR01AI116577 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI GAZZINELLI, RICARDO TOSTES, LIEBERMAN, JUDY · 2016 to 2020
$3.2M
6 · The paper itself

Abstract

CD8+ T lymphocytes play an important role in controlling infections by intracellular pathogens. Chemokines and their receptors are crucial for the migration of CD8+ T-lymphocytes, which are the main IFNγ producers and cytotoxic effectors cells. Although the participation of chemokine ligands and receptors has been largely explored in viral infection, much less is known in infection by Trypanosoma cruzi, the causative agent of Chagas disease. After T. cruzi infection, CXCR3 chemokine receptor is highly expressed on the surface of CD8+ T-lymphocytes. Here, we hypothesized that CXCR3 is a key molecule for migration of parasite-specific CD8+ T-cells towards infected tissues, where they may play their effector activities. Using a model of induction of resistance to highly susceptible A/Sn mice using an ASP2-carrying DNA/adenovirus prime-boost strategy, we showed that CXCR3 expression was upregulated on CD8+ T-cells, which selectively migrated towards its ligands CXCL9 and CXCL10. Anti-CXCR3 administration reversed the vaccine-induced resistance to T. cruzi infection in a way associated with hampered cytotoxic activity and increased proapoptotic markers on the H2KK-restricted TEWETGQI-specific CD8+ T-cells. Furthermore, CXCR3 receptor critically guided TEWETGQI-specific effector CD8+ T-cells to the infected heart tissue that express CXCL9 and CXCL10. Overall, our study pointed CXCR3 and its ligands as key molecules to drive T. cruzi-specific effector CD8+ T-cells into the infected heart tissue. The unveiling of the process driving cell migration and colonization of infected tissues by pathogen-specific effector T-cells is a crucial requirement to the development of vaccine strategies.

Indexed as

Chemotaxis, LeukocyteAdenovirus VaccinesAnimalsApoptosisCD8-Positive T-LymphocytesChagas CardiomyopathyFemaleHeartLigandsMiceMice, Inbred C57BLMyocardiumReceptors, CCR2Receptors, CXCR3SpleenTrypanosoma cruziAdenovirus VaccinesCcr2 protein, mouseCxcr3 protein, mouseLigandsReceptors, CCR2Receptors, CXCR3Vaccines, DNA

Identifiers

PMID31356587
PMCPMC6687206
OpenAlexW2965198478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.